Income Statement (TTM)
Britannia Life Sciences Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 3 | 5 | 7 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 1 | -1 | -1 | -1 | 0 | 0 |
| Change (%) | 138.62 | 56.47 | 31.18 | 4.62 | -6.38 | -4.75 | -0.09 | -1.54 | 6.93 | 6.99 | 2.16 | -93.10 | -347.83 | 9.24 | 5.21 | -125.09 | 3.80 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | -0 | -0 | 0 | 0 | 0 |
| Change (%) | 171.75 | 65.19 | 39.10 | 31.92 | -0.69 | -2.44 | -0.74 | -9.91 | 3.94 | 11.20 | 9.03 | -82.96 | -111.76 | -99.72 | -98,008.87 | 181.66 | 24.77 | |
| % of Revenue | 17.37 | 19.78 | 20.88 | 22.14 | 27.92 | 29.61 | 30.33 | 30.14 | 27.57 | 26.80 | 27.85 | 29.73 | 73.35 | 3.48 | 0.01 | -8.25 | 92.60 | 111.31 |
| Gross Operating Profit | 1 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 0 | -1 | -1 | -2 | 0 | -0 |
| Change (%) | 131.66 | 54.32 | 29.09 | -3.15 | -8.58 | -5.73 | 0.19 | 2.07 | 8.08 | 5.46 | -0.49 | -97.38 | -997.71 | 13.17 | 13.89 | -101.71 | -258.66 | |
| % of Revenue | 82.63 | 80.22 | 79.12 | 77.86 | 72.08 | 70.39 | 69.67 | 69.86 | 72.43 | 73.20 | 72.15 | 70.27 | 26.65 | 96.52 | 99.99 | 108.25 | 7.40 | -11.31 |
| SG&A | 1 | 1 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 2 | 1 | 1 | 1 | 2 | 2 |
| Change (%) | 66.12 | 32.27 | 49.94 | 40.27 | 13.50 | 8.60 | -1.89 | -17.37 | -4.94 | 7.34 | 8.29 | -58.12 | -25.70 | -34.17 | 1.18 | 168.79 | -1.91 | |
| % of Revenue | 55.38 | 38.56 | 32.59 | 37.25 | 49.95 | 60.56 | 69.05 | 67.81 | 56.90 | 50.58 | 50.75 | 53.79 | 326.25 | -97.81 | -58.94 | -56.68 | 607.37 | 574.00 |
| R&D | ||||||||||||||||||
| Change (%) | ||||||||||||||||||
| % of Revenue | ||||||||||||||||||
| OpEx | 1 | 2 | 3 | 4 | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 6 | 2 | 1 | 1 | 1 | 3 | 3 |
| Change (%) | 83.30 | 41.34 | 44.16 | 33.93 | 8.42 | 4.98 | -1.54 | -15.07 | -2.04 | 8.68 | 8.55 | -66.96 | -40.79 | -31.37 | 15.64 | 166.34 | 1.66 | |
| % of Revenue | 79.77 | 61.27 | 55.35 | 60.83 | 77.87 | 90.17 | 99.38 | 97.94 | 84.48 | 77.38 | 78.60 | 83.52 | 399.60 | -95.47 | -59.98 | -65.93 | 699.97 | 685.55 |
| Operating Income | 0 | 1 | 2 | 3 | 2 | 1 | 0 | 0 | 1 | 2 | 2 | 1 | -2 | -3 | -2 | -2 | -2 | -2 |
| Change (%) | 356.78 | 80.41 | 15.10 | -40.89 | -58.42 | -93.98 | 231.33 | 642.10 | 55.80 | 1.23 | -21.32 | -225.51 | 61.69 | -10.59 | 9.12 | -9.29 | 1.30 | |
| % of Revenue | 20.23 | 38.73 | 44.65 | 39.17 | 22.13 | 9.83 | 0.62 | 2.06 | 15.52 | 22.62 | 21.40 | 16.48 | -299.60 | 195.47 | 159.98 | 165.93 | -599.97 | -585.55 |
| Interest Expense | -0 | -1 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | |||
| Change (%) | 207.87 | 78.28 | 26.28 | -6.83 | -22.73 | -36.81 | -27.04 | 3.60 | 6.04 | 18.51 | 7.81 | -91.49 | -3.05 | |||||
| % of Revenue | -25.15 | -32.45 | -36.97 | -35.59 | -31.70 | -26.16 | -17.35 | -12.67 | -13.33 | -13.22 | -14.64 | -15.45 | -19.05 | -28.75 | -26.85 | |||
| Net Income | -0 | 0 | -0 | -10 | -15 | -13 | -11 | -1 | 5 | 2 | 1 | 2 | -5 | -5 | -7 | -8 | 7 | 7 |
| Change (%) | -407.37 | -136.01 | 5,681.59 | 53.72 | -18.08 | -15.44 | -92.57 | -739.21 | -69.55 | -27.84 | 52.79 | -379.38 | 13.01 | 35.61 | 9.20 | -192.65 | 0.64 | |
| % of Revenue | -11.03 | 14.21 | -3.27 | -144.11 | -211.76 | -185.28 | -164.49 | -12.23 | 79.39 | 22.60 | 15.24 | 22.80 | -922.51 | 420.67 | 522.20 | 542.02 | 2,001.95 | 1,941.02 |
Source: Capital IQ
